HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Woodrow, C J Articles by Krishna, S Search for Related Content PubMed PubMed Citation Articles by Woodrow, C J Articles by Krishna, S

Artemisinins

¹ Department of Cellular and Molecular Medicine, Infectious Diseases, St George’s Hospital Medical School, Tooting, London, UK
² Department of Chemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong

Correspondence to:
Correspondence to:
Professor S Krishna
Department of Cellular and Molecular Medicine, Infectious Diseases, St George’s Hospital Medical School, Cranmer Terrace, Tooting, London SW17 0RE, UK; s.krishna{at}sghms.ac.uk

Artemisinins were discovered to be highly effective antimalarial drugs shortly after the isolation of the parent artemisinin in 1971 in China. These compounds combine potent, rapid antimalarial activity with a wide therapeutic index and an absence of clinically important resistance. Artemisinin containing regimens meet the urgent need to find effective treatments for multidrug resistant malaria and have recently been advocated for widespread deployment. Comparative trials of artesunate and quinine for severe malaria are in progress to see if the persistently high mortality of this condition can be reduced.

Keywords: artemisinin; qinghaosu; malaria; multidrug resistant; PfATPase6

This article has been cited by other articles:

				V. Sinou, N. Taudon, J. Mosnier, C. Aglioni, F. M. M. Bressolle, and D. Parzy Pharmacokinetics of artesunate in the domestic pig J. Antimicrob. Chemother., June 16, 2008; (2008) dkn231v1. [Abstract] [Full Text] [PDF]

				P. J. Rosenthal Artesunate for the Treatment of Severe Falciparum Malaria N. Engl. J. Med., April 24, 2008; 358(17): 1829 - 1836. [Full Text] [PDF]

				L. OSORIO, C. MURILLO, S. APONTE, V. MAYAGAYA, C. SCHEURER, R. BRUN, H. MATILE, and S. WITTLIN IN VITRO SUSCEPTIBILITY OF P. FALCIPARUM POPULATIONS FROM COLOMBIA AND TANZANIA TO A NEW SYNTHETIC PEROXIDE (OZ277) Am J Trop Med Hyg, June 1, 2007; 76(6): 1024 - 1026. [Abstract] [Full Text] [PDF]

				Y. V. Mishina, S. Krishna, R. K. Haynes, and J. C. Meade Artemisinins Inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense In Vitro Growth Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1852 - 1854. [Abstract] [Full Text] [PDF]

				A.-C. Uhlemann, S. Wittlin, H. Matile, L. Y. Bustamante, and S. Krishna Mechanism of Antimalarial Action of the Synthetic Trioxolane RBX11160 (OZ277) Antimicrob. Agents Chemother., February 1, 2007; 51(2): 667 - 672. [Abstract] [Full Text] [PDF]

				S. Maerki, R. Brun, S. A. Charman, A. Dorn, H. Matile, and S. Wittlin In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum J. Antimicrob. Chemother., July 1, 2006; 58(1): 52 - 58. [Abstract] [Full Text] [PDF]

				J. Keiser, R. Brun, B. Fried, and J. Utzinger Trematocidal Activity of Praziquantel and Artemisinin Derivatives: In Vitro and In Vivo Investigations with Adult Echinostoma caproni Antimicrob. Agents Chemother., February 1, 2006; 50(2): 803 - 805. [Abstract] [Full Text] [PDF]